rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-4-15
|
pubmed:abstractText |
E-cadherin is an epithelial cell adhesion molecule, and decreased E-cadherin expression in human prostate cancer is associated with tumor grade and advanced clinical stage. A -160 C-->A polymorphism in the promoter region of E-cadherin has been shown to decrease gene transcription. This allelic variation may be a potential genetic marker that can help identify those individuals at higher risk for invasive/metastatic disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0042-1138
|
pubmed:author |
pubmed-author:HamasakiTakashiT,
pubmed-author:ImaiHirohisaH,
pubmed-author:InatomiHisatoH,
pubmed-author:KatohTakahikoT,
pubmed-author:KohshiKiyotakaK,
pubmed-author:KomiyaYasuhiroY,
pubmed-author:KurodaYoshikiY,
pubmed-author:NakaoHiroyukiH,
pubmed-author:OsadaYukioY,
pubmed-author:QiuDelaiD,
pubmed-author:TsukinoHiromasaH
|
pubmed:copyrightInfo |
Copyright 2004 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
203-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
|
pubmed:year |
2004
|
pubmed:articleTitle |
Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer.
|
pubmed:affiliation |
Department of Public Health, Miyazaki Medical College, University of Miyazaki, Miyazaki, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|